Nonsteroidal anti-inflammatory drugs in Alzheimer's disease.
about
Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's diseaseAspirin and anti-inflammatory drugs for Alzheimer's diseaseAlzheimer's disease; taking the edge off with cannabinoids?Bioenergetic dysfunction and inflammation in Alzheimer's disease: a possible connectionInflammation and Alzheimer's diseaseSalicylic acid in the serum of subjects not taking aspirin. Comparison of salicylic acid concentrations in the serum of vegetarians, non-vegetarians, and patients taking low dose aspirinStructural requirements for the neuroprotective effects of aspirin analogues against N-methyl-D-aspartate and zinc ion neurotoxicityAcetaminophen inhibits neuronal inflammation and protects neurons from oxidative stressImplication of Complement System and its Regulators in Alzheimer’s DiseaseYY-1224, a terpene trilactone-strengthened Ginkgo biloba, attenuates neurodegenerative changes induced by β-amyloid (1-42) or double transgenic overexpression of APP and PS1 via inhibition of cyclooxygenase-2.Identification of cathepsin B as a mediator of neuronal death induced by Abeta-activated microglial cells using a functional genomics approach.NO-flurbiprofen reduces amyloid-beta, is neuroprotective in cell culture, and enhances cognition in response to cholinergic blockade.The prediction and prevention of Alzheimer's disease--towards a research agendaInhibition of amyloidogenesis by nonsteroidal anti-inflammatory drugs and their hybrid nitratesMild cognitive impairment: potential pharmacological treatment options.Neuronal overexpression of cyclooxygenase-2 does not alter the neuroinflammatory response during brain innate immune activation.Adaptive immune regulation of glial homeostasis as an immunization strategy for neurodegenerative diseasesApoptosis modulators in the therapy of neurodegenerative diseases.COX-2 and Alzheimer's disease: potential roles in inflammation and neurodegeneration.Preventing dementia.Microglial interaction with beta-amyloid: implications for the pathogenesis of Alzheimer's disease.Toll-like receptors in Alzheimer's diseaseInflammation, apoptosis, and Alzheimer's disease.Prevention of Alzheimer's disease: where we stand.Cyclooxygenase-2 inhibitors: promise or peril?Risk factors for Alzheimer's disease: role of multiple antioxidants, non-steroidal anti-inflammatory and cholinergic agents alone or in combination in prevention and treatment.Long-term cholinesterase inhibitor therapy for Alzheimer's disease: implications for long-term care.The microglial NADPH oxidase complex as a source of oxidative stress in Alzheimer's diseaseInflammation and the pathophysiology of Alzheimer's disease.PMC-12, a Prescription of Traditional Korean Medicine, Improves Amyloid β-Induced Cognitive Deficits through Modulation of Neuroinflammation.Current concepts in the prevention of Alzheimer's disease.Neuronal death in Alzheimer's disease and therapeutic opportunities.HIV-1 Tat-induced microglial activation and neuronal damage is inhibited via CD45 modulation: A potential new treatment target for HAND.Fallacies in the pathological confirmation of the diagnosis of Alzheimer's disease.Diabetes, sugar-coated but harmful to the brain.Factors affecting the age of onset and rate of progression of Alzheimer's disease.Inflammatory changes parallel the early stages of Alzheimer disease.Is there a future for cyclo-oxygenase inhibitors in Alzheimer's disease?Dementia and its implications for public health.Alzheimer's disease, brain immune privilege and memory: a hypothesis.
P2860
Q24203739-532C36A7-2B91-4367-8C83-A15DE945F12BQ24243604-41BFEC47-BED1-4978-ABD2-6C25BDD62FB2Q24681412-B65CBC58-9E72-4D9C-A725-0C5869E4B529Q26822410-941740FD-F22C-47BB-8C62-C835BD4078FEQ28138617-175CE20A-6831-4D31-9A26-2F001463045EQ28185899-7C6C4CBE-7784-49B3-A3D3-85642535FFEFQ28193550-6610271C-4EBA-490C-8F64-C490E9576697Q28576204-D9551D42-FF00-44EB-A751-2158647271CCQ28972502-FBCCED9E-7F4F-4620-B6AE-13493C2F3B30Q30847206-B45A3C4C-F801-4303-A788-F42C55695995Q31023855-47F0D130-5F8B-4450-ACEF-5153A72FE209Q33496256-3D415E4B-7814-42F1-BDD6-B315B5CA6B10Q33787542-89D086D8-9B6A-4334-B9B1-81BFB5A7A98AQ33846317-1727B38D-3263-4BFA-B898-060A58A379CAQ33911331-031BB5AC-796D-4C43-A916-7BE02F1AE6ECQ33936122-234CE81B-9DA9-41B9-8D1D-CC516FF18B0DQ34071942-9342C1C4-5826-440F-9187-E27D6C9E4B56Q34074800-DF8584AF-8CD8-4535-BF64-49A34CF6B9A0Q34119479-CC9B045F-89DC-41D9-B4CD-5C92C0BD8795Q34174220-350C9606-3E6E-4241-A234-D463B57033C2Q34309544-16674492-8FA4-46E8-AAE9-D9C55FF614A2Q34548586-9C962419-7A1A-4032-9398-DAC2F921994FQ34682170-31604804-B8DC-485A-8EED-B5F73BC05FF3Q34778089-EB6A6768-B465-4040-B46D-6440CE4E6F6CQ35017693-19DA2DA8-0D31-4524-8162-A55A2AC23BE6Q35025023-2DEF4C37-B19B-4B2E-BA81-6787025FA13FQ35112092-7B3FFD78-2654-41D7-9311-90CF72C5BB7CQ35132234-C9459E2D-DB01-4983-9D36-934FEC271EE1Q35236248-7BF64FDE-4380-4E2C-BE53-2D9DBBFEE140Q35511034-B9CD79BA-FDA1-4110-B334-D5DE4772DD05Q35618929-33C01A86-7960-492E-BB8B-C54A9EFF6600Q35889067-E486E75A-0B98-4962-ACA3-4C6C5CC2DFA2Q36185385-73078D35-52F1-4ADE-9545-A78957016462Q36317646-606F379F-C312-44F7-BA3A-310F3219A168Q36318129-FE41D377-B552-42D4-9F8F-D9CBF6263FD3Q36318577-E91DC2BD-930E-4084-9324-BE48896B33B4Q36380232-9DCC8191-B6DF-4C1E-9FD2-53B0DC7EC13EQ36396392-CA022211-32CE-4D14-BB08-32736185193DQ36422185-184C5183-EB2E-4169-8541-09D7AC061BACQ36577655-3F0B6266-C9EF-4474-832C-0E9DC61C9D6B
P2860
Nonsteroidal anti-inflammatory drugs in Alzheimer's disease.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Nonsteroidal anti-inflammatory drugs in Alzheimer's disease.
@en
Nonsteroidal anti-inflammatory drugs in Alzheimer's disease.
@nl
type
label
Nonsteroidal anti-inflammatory drugs in Alzheimer's disease.
@en
Nonsteroidal anti-inflammatory drugs in Alzheimer's disease.
@nl
prefLabel
Nonsteroidal anti-inflammatory drugs in Alzheimer's disease.
@en
Nonsteroidal anti-inflammatory drugs in Alzheimer's disease.
@nl
P2093
P356
P1433
P1476
Nonsteroidal anti-inflammatory drugs in Alzheimer's disease.
@en
P2093
P356
10.1212/WNL.45.1.51
P407
P577
1995-01-01T00:00:00Z